retatrutide clinical trials weight loss New Phase 3 data just dropped 👀 Eli Lilly's trial reported average approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Retatrutide: The Breakthrough Shot Revolutionizing

Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Zannad F

Back Laughton, NB, Macallum, AB (1 June 1932) 'The Relation of duodenal mucosa to internal secretion of the pancreas', Proceedings of the Royal Society of London

Simonsen L, Holst JJ, Madsen K, Deacon CF

Consistent daily routine: Some patients find it easier to stay disciplined when the medication is part of their daily morning ritual

Tirzepatide focuses on dual receptor activity

Edvardsson CE, Cadeddu D, Ericson M, Adermark L, Jerlhag E (2025) An inhibitory GLP-1 circuit in the lateral septum modulates reward processing and alcohol intake in rodents